Proposed environment 05
Make evidence traceable, authority explicit and decisions reviewable.
Provide the proposed trust and evidence architecture across the campus.
Whether evidence, controls and accountable authority support programme progression.
Lower evidence debt and clearer future diligence, quality and regulatory handoffs.
Proposed purpose
The proposed building would place quality systems, data stewardship, regulatory planning and programme governance alongside one another. Its intended role would be to make responsibilities, evidence status and unresolved risks visible before technical or capital commitments advanced.
Where value could be created
The proposed environment could protect programme value by connecting material claims to source evidence, owners, review dates and decision authority. Future diligence could become clearer by separating verified evidence, assumptions, unresolved gaps and reserved information.
Gaps, assumptions, ownership and review dates could be visible before they become expensive programme problems.
Scientific, process, supplier and system changes could be assessed against quality and regulatory implications.
Source records and access controls could allow appropriate reviewers to inspect evidence without exposing reserved material.
Advance, remediate, pause and stop decisions could connect evidence to named authority.
Capital should follow evidence, repeat demand and accountable delivery. The building would not advance merely because the concept is visually compelling.
Illustrative proposed activities
The examples below are proposed assurance exercises. They do not represent a certified quality system, approved submission, regulator interaction or current regulated service.
Teams could test whether a scientific claim can be traced to its source data, method, sample, owner and review decision.
Controlled records, laboratory information systems, audit logs, identity controls and evidence maps.
A lineage gap assessment and remediation priorities.
System selection and validation would depend on intended use, risk, legal scope and accountable ownership.Teams could test record retrieval, access control, deviation handling, corrective action and decision authority against a defined scenario.
Electronic quality management, controlled documents, secure review rooms and action tracking.
An audit readiness view with evidence and control gaps.
A rehearsal would not imply certification, inspection readiness or regulator endorsement.Teams could examine how a proposed material, process, method, supplier or system change affects evidence and controls.
Change control workflows, risk tools, versioned records, dependency maps and accountable review.
An approve, gather more evidence, redesign or reject recommendation.
Formal change authority would sit with the legally and operationally accountable organisation.Teams could compare possible evidence routes, dependencies and gaps for a defined product and development stage.
Regulatory knowledge tools, controlled source libraries, dossier maps and decision records.
A route assumption map and evidence plan for specialist review.
The exercise would not imply regulator advice, acceptance, approval or a guaranteed route.Innovation architecture
The proposed innovation model would treat evidence as an organised programme asset rather than a collection of files. Lineage, controlled terminology, review trails and secure access could support future decisions and diligence.
Material statements could connect to source records, ownership, confidence and review dates.
Access could be separated by programme, tenant, role and confidentiality need.
Quality, scientific, commercial and sponsor responsibilities could be explicit at every gate.
For the public reader
In plain English, this building could help future Scottish science programmes organise what they know, what they do not know and who is responsible before seeking investment, approval or scale.
Controlled methods, clear data history and decision records could show what happened and who approved it.
Qualified leadership, governed systems, validation, secure access and legal responsibility.
A shared model could help smaller teams understand quality, data and regulatory needs earlier.
A viable service model, experienced professionals and defined accountability.
Potential paths could include quality, regulatory affairs, data governance, records and cyber security.
Funded roles, recognised training, experienced supervision and sustained demand.
Secure evidence rooms and traceable records could help appropriate partners conduct technical review.
Complete source evidence and independent diligence. Better organisation would not guarantee finance or approval.
These are potential outcomes, not current impacts. Delivery depends on funded demand, permissions, qualified operators, formal partners, safe operating systems and a credible commercial plan.
From concept to an operating case
Defined assistance within an explicit legal, professional and operating scope.
Evidence mapping and route assumptions for qualified specialist review.
Controlled source evidence for appropriate investors, sponsors and counterparties.
Controlled methods, sample knowledge and formulation decisions.
ReceivesTranslational DevelopmentProtocols, study evidence, limitations and decision records.
Hands forwardAdvanced Medicines ManufacturingQuality requirements, regulatory assumptions and controlled transfer evidence.
Evidence required before delivery
Defined accountable organisation for each activity and its intended regulated scope
Accountable quality leadership and professional responsibilities
Validation, privacy, security, retention and tenant segregation
Operating procedures, service demand, audit model and finance
These links provide background to selected technical or policy concepts. They do not substantiate delivery, endorse VARUNÉ Labs or prove current capability or regional impact.
